Ticker Details
Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
IPO Date:	October 15, 2020
Sector:	Technology
Industry:	Solar
Market Cap:	$1.3B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 3.33%
Avg Daily Range (30 D):	$0.22 | 2.75%
Avg Daily Range (90 D):	$0.28 | 3.17%

Institutional Daily Volume
Avg Daily Volume:	4.48M
Avg Daily Volume (30 D):	4.32M
Avg Daily Volume (90 D):	4.96M

Trade Size
Avg Trade Size (Sh.):	123
Avg Trade Size (Sh.) (30 D):	122
Avg Trade Size (Sh.) (90 D):	119

Institutional Trades
Total Institutional Trades:	6,475
Avg Institutional Trade:	$2.33M
Avg Institutional Trade (30 D):	$3.6M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.07M
Avg Closing Trade (30 D):	$7.25M
Avg Closing Trade (90 D):	$5.64M
Avg Closing Volume:	390.01K

News

Feb 10, 2026 @ 3:00 PM Array Acquires Chimney to Expand Digital Financial... Source: Not Specified

Jan 20, 2026 @ 10:10 PM 3 Bold Predictions to Start 2026 Source: Motley Fool Staff

Jan 13, 2026 @ 7:02 PM Where Will Nextpower (NXT) Stock Be in 1 Year? Source: Leo Sun

Sep 28, 2025 @ 11:30 AM Is Nextracker Stock a Buy Now? Source: Leo Sun

Aug 21, 2025 @ 12:00 PM Shoals Technologies Group Appoints Aaron Zadeh as ... Source: Shoals Technologies Group

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.83	$-.09	$-1.05
Diluted EPS	$-.83	$-.09	$-1.05
Revenue	$1.21B	$223.41M	$226.04M
Gross Profit	$285.13M	$63M	$19.33M
Net Income / Loss	$-66.98M	$2M	$-145.75M
Operating Income / Loss	$-49.17M	$7.11M	$-148.11M
Cost of Revenue	$920.06M	$160.41M	$206.71M
Net Cash Flow	$-147.5M	$-43.99M	$22.88M
PE Ratio